Exact Mass: 881.4357

Exact Mass Matches: 881.4357

Found 20 metabolites which its exact mass value is equals to given mass value 881.4357, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Elbasvir

methyl N-{1-[2-(5-{5-[2-(1-{2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl)-1H-imidazol-5-yl]-9-phenyl-8-oxa-10-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(17),2(7),3,5,11(16),12,14-heptaen-14-yl}-1H-imidazol-2-yl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate

C49H55N9O7 (881.4224)


   

Nostocyclopeptide M1

Nostocyclopeptide M1

C47H59N7O10 (881.4323)


   
   
   

(3beta)-7-oxosolanid-5-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1?2)-[beta-D-glucopyranosyl-(1?3)]-beta-D-galactopyranoside

(3beta)-7-oxosolanid-5-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1?2)-[beta-D-glucopyranosyl-(1?3)]-beta-D-galactopyranoside

C45H71NO16 (881.4773)


   

Elbasvir

Elbasvir

C49H55N9O7 (881.4224)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent COVID info from DrugBank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Tesetaxel

Tesetaxel

C46H60FN3O13 (881.411)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

   
   

5'-ODMT cEt G Phosphoramidite (Amidite)

5'-ODMT cEt G Phosphoramidite (Amidite)

C46H56N7O9P (881.3877)


5'-ODMT cEt G Phosphoramidite Amidite is a potent nucleic acid analog. 5'-ODMT cEt G Phosphoramidite Amidite shows excellent safety and antisense activity[1][2].

   

3-methyl-2-[({2,5,11,14-tetrahydroxy-6-[2-(4-hydroxyphenyl)ethyl]-7-methyl-3-[2-(methylsulfanyl)ethyl]-8-oxo-9-(2-phenylethyl)-12-(sec-butyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]pentanoic acid

3-methyl-2-[({2,5,11,14-tetrahydroxy-6-[2-(4-hydroxyphenyl)ethyl]-7-methyl-3-[2-(methylsulfanyl)ethyl]-8-oxo-9-(2-phenylethyl)-12-(sec-butyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]pentanoic acid

C45H67N7O9S (881.4721)


   

(6s,9s,12s,15s,18r,23as)-6-benzyl-4,10,13-trihydroxy-9,18-bis[(4-hydroxyphenyl)methyl]-12-isopropyl-2,8,17-trimethyl-15-(2-methylpropyl)-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosane-1,7,16,19-tetrone

(6s,9s,12s,15s,18r,23as)-6-benzyl-4,10,13-trihydroxy-9,18-bis[(4-hydroxyphenyl)methyl]-12-isopropyl-2,8,17-trimethyl-15-(2-methylpropyl)-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosane-1,7,16,19-tetrone

C48H63N7O9 (881.4687)


   

(5r,8s,11r,15s,18s,19s,22r)-3,6,9,13,16,20-hexahydroxy-18-[(1e,3e,5s,6s)-6-hydroxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,15,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11,22-dicarboxylic acid

(5r,8s,11r,15s,18s,19s,22r)-3,6,9,13,16,20-hexahydroxy-18-[(1e,3e,5s,6s)-6-hydroxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,15,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11,22-dicarboxylic acid

C44H63N7O12 (881.4534)


   

6-benzyl-4,10,13-trihydroxy-9,18-bis[(4-hydroxyphenyl)methyl]-12-isopropyl-2,8,17-trimethyl-15-(2-methylpropyl)-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosane-1,7,16,19-tetrone

6-benzyl-4,10,13-trihydroxy-9,18-bis[(4-hydroxyphenyl)methyl]-12-isopropyl-2,8,17-trimethyl-15-(2-methylpropyl)-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosane-1,7,16,19-tetrone

C48H63N7O9 (881.4687)


   

(2e,4e,6e,8e,10e)-n-[(1s)-1-{[(3s,7s,13s,16s,19s)-15-hydroxy-13,16,17-trimethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)dodeca-2,4,6,8,10-pentaenediimidic acid

(2e,4e,6e,8e,10e)-n-[(1s)-1-{[(3s,7s,13s,16s,19s)-15-hydroxy-13,16,17-trimethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)dodeca-2,4,6,8,10-pentaenediimidic acid

C46H55N7O11 (881.3959)


   

[(2r,3r,6r)-6-[(1r)-1-{[(3r,13r,20s,21s,24s,27s)-12,26-dihydroxy-24-[(1r)-1-hydroxyethyl]-21-isopropyl-2,9,19,23-tetraoxo-22-oxa-1,7,8,11,17,18,25,31-octaazatetracyclo[25.4.0.0³,⁸.0¹³,¹⁸]hentriaconta-11,25-dien-20-yl]-c-hydroxycarbonimidoyl}-1-hydroxyethyl]-2-ethyl-6-hydroxyoxan-3-yl]acetic acid

[(2r,3r,6r)-6-[(1r)-1-{[(3r,13r,20s,21s,24s,27s)-12,26-dihydroxy-24-[(1r)-1-hydroxyethyl]-21-isopropyl-2,9,19,23-tetraoxo-22-oxa-1,7,8,11,17,18,25,31-octaazatetracyclo[25.4.0.0³,⁸.0¹³,¹⁸]hentriaconta-11,25-dien-20-yl]-c-hydroxycarbonimidoyl}-1-hydroxyethyl]-2-ethyl-6-hydroxyoxan-3-yl]acetic acid

C39H63N9O14 (881.4494)


   

(3s,6s,12r,19e,26s)-5,14,17,23-tetrahydroxy-12-(2-hydroxyethyl)-15,18,21-tris[(4-hydroxyphenyl)methyl]-3-isopropyl-26-methyl-1,4,10,13,16,19,22-heptaazatricyclo[22.3.0.0⁶,¹⁰]heptacosa-4,13,16,19,22-pentaene-2,11-dione

(3s,6s,12r,19e,26s)-5,14,17,23-tetrahydroxy-12-(2-hydroxyethyl)-15,18,21-tris[(4-hydroxyphenyl)methyl]-3-isopropyl-26-methyl-1,4,10,13,16,19,22-heptaazatricyclo[22.3.0.0⁶,¹⁰]heptacosa-4,13,16,19,22-pentaene-2,11-dione

C47H59N7O10 (881.4323)


   

2-[({3-[(acetyloxy)methyl]-2,5,11,14-tetrahydroxy-7-methyl-12-[2-(methylsulfanyl)ethyl]-8-oxo-6,9-bis(2-phenylethyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]-3-methylpentanoic acid

2-[({3-[(acetyloxy)methyl]-2,5,11,14-tetrahydroxy-7-methyl-12-[2-(methylsulfanyl)ethyl]-8-oxo-6,9-bis(2-phenylethyl)-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]-3-methylpentanoic acid

C44H63N7O10S (881.4357)


   

(2e,4e,6e,8e,10e)-n-[1-({15-hydroxy-13,16,17-trimethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl}-c-hydroxycarbonimidoyl)-2-phenylethyl]-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)dodeca-2,4,6,8,10-pentaenediimidic acid

(2e,4e,6e,8e,10e)-n-[1-({15-hydroxy-13,16,17-trimethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl}-c-hydroxycarbonimidoyl)-2-phenylethyl]-n'-(2-hydroxy-5-oxocyclopent-1-en-1-yl)dodeca-2,4,6,8,10-pentaenediimidic acid

C46H55N7O11 (881.3959)


   

(5r,8s,11r,15s,18s,19s,22r)-3,6,9,13,16,20-hexahydroxy-8-isopropyl-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,15,19-tetramethyl-2-methylidene-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11,22-dicarboxylic acid

(5r,8s,11r,15s,18s,19s,22r)-3,6,9,13,16,20-hexahydroxy-8-isopropyl-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,5,15,19-tetramethyl-2-methylidene-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11,22-dicarboxylic acid

C44H63N7O12 (881.4534)


   

(3s,6s,12r,26s)-5,14,17,23-tetrahydroxy-12-(2-hydroxyethyl)-15,18,21-tris[(4-hydroxyphenyl)methyl]-3-isopropyl-26-methyl-1,4,10,13,16,19,22-heptaazatricyclo[22.3.0.0⁶,¹⁰]heptacosa-4,13,16,19,22-pentaene-2,11-dione

(3s,6s,12r,26s)-5,14,17,23-tetrahydroxy-12-(2-hydroxyethyl)-15,18,21-tris[(4-hydroxyphenyl)methyl]-3-isopropyl-26-methyl-1,4,10,13,16,19,22-heptaazatricyclo[22.3.0.0⁶,¹⁰]heptacosa-4,13,16,19,22-pentaene-2,11-dione

C47H59N7O10 (881.4323)